Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
- Model
- CDMO
- Manufacturer?
- Yes
8 companies are listed as peptide CDMOs in India. 7 hold active US Drug Master Files for peptide APIs, most often for Desmopressin, Liraglutide, Octreotide. 7 have a regulator record of GMP manufacturing. 8 score High (90 or more).
Ordered by score. Scores follow the published rules and are not affected by paid placement. Updated 2026-11-13.
Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
Hyderabad injectables CDMO founded 1978, promoted by Fosun Pharma; FDA-inspected sites; US DMF for glatiramer acetate.
Hyderabad-based MSN Group entity holding US DMFs for 11 peptide APIs, including semaglutide and tirzepatide. MSN runs 27 plants in India, the USA and Indonesia.
Indian CDMO whose Turbhe, Navi Mumbai site develops and makes peptide APIs by solid- and solution-phase synthesis. Holds US DMFs for 9 peptide APIs.
Raichur API and CDMO subsidiary of Shilpa Medicare; US DMFs for desmopressin, liraglutide and octreotide; Raichur units inspected by US FDA in 2025.
Indian API manufacturer and CDMO with a peptide synthesis platform.
Mumbai peptide API maker acquired by Piramal Pharma in 2021; its oxytocin API is WHO-prequalified; US DMF for oxytocin.
Indian contract research, development and manufacturing organization (CRDMO) listed on NSE and BSE. It has opened a dedicated Peptide Research Center in Hyderabad.
8 companies. Each listing shows location, business model, documentation and a score from 0 to 100.
By score: Auro Peptides Ltd (98), Gland Pharma Ltd (98), MSN Life Sciences Private Ltd (MSN Group) (98), Piramal Pharma Ltd (Piramal Pharma Solutions) (98), Shilpa Pharma Lifesciences Ltd (98). Scores measure checkable evidence, not product quality, and paid placement does not change them.
Auro Peptides Ltd, Gland Pharma Ltd, MSN Life Sciences Private Ltd (MSN Group), Piramal Pharma Ltd (Piramal Pharma Solutions), Shilpa Pharma Lifesciences Ltd, Neuland Laboratories and Hemmo Pharmaceuticals Pvt Ltd (Piramal Pharma Solutions) hold active Type II DMFs for peptide APIs in FDA's DMF list. A DMF is a confidential file submitted to FDA; FDA does not approve DMFs, but drug applications can reference them.
Confirm the legal entity, ask for lot-specific certificates of analysis that the testing lab can verify, check FDA warning letters and import alerts, and for GMP material ask for regulator inspection records rather than marketing claims.